Alzheimers Disease: – Durect to pay Voyager $1M in amended deal
Durect to pay Voyager $1M in amended deal
Drug delivery technology company Durect Corp. will pay Voyager Pharmaceutical Corp. $1 million and forgive debt in exchange for doubling the rate of royalties it receives for an Alzheimer’s disease treatment under development.
Gene linked to Alzheimer’s identified
WASHINGTON: Scientists said on Sunday they have pinpointed a new gene linked to Alzheimer’s disease, the incurable brain disorder that is the top cause of dementia in the elderly.
Now an Alzheimer’s vaccine ‘in a patch’
London, Jan 23 : A patch which delivers a vaccine against Alzheimer’s disease through the skin has been shown to be safe and effective, according to a new study .
Sarasota’s Roskamp Institute Discovers New Class of Drugs That Can Impact Alzheimer’s Disease
The Roskamp Institute announced today the discovery of a new class of drugs that lower the production of the main pathological protein that causes Alzheimer’s disease.
How brain protein turns toxic in Alzheimer’s disease
The long-suspected link between Alzheimer’s disease and abnormalities in the way amyloid protein is processed in the brain is confirmed at last
Related posts:
- Alzheimers Disease: – Voyager Adds Alzheimer’s Experts To Its Scientific Advisory Board
- Alzheimers Disease: – Caregivers’ Corner: Staff should be trained to deal with dementia
- Alzheimer’s Research Among Science Efforts at Stake in Debt Deal
- How to deal with Alzheimer’s and dementia in Arizona
- U.S. team discovers new Alzheimer’s risk gene